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Abstract
Objective
To determine factors associated with differential changes in body fat, insulin resistance and
aerobic capacity following a 12-week exercise intervention in overweight and obese women
with and without polycystic ovary syndrome (PCOS).
Methods
16 overweight and obese women (9 PCOS; 7 without PCOS) completed a supervised pro-
gressive 12-week exercise program. Primary outcomes included changes in indicators of
insulin sensitivity (including glucose infusion rate relative to fat-free mass [GIR/FFM]), body
composition, and aerobic capacity (VO2 peak; 12 participants only). Comparisons were
made between women with and without PCOS, and between participants who lost5%
(classified as exercise responders) and <5% (non-responders) in body fat (assessed by
dual-energy X-ray absorptiometry).
Results
Training decreased body fat percentage by (mean; 95% CI) -2.3%; -5.3, 0.7% in women
with PCOS and by -6.4%; -10.9, -1.9% in women without PCOS (P = 0.08). Ten women (7
PCOS; 3 without PCOS) did not reduce body fat by5%. All participants improved VO2
peak (mean change 27%; 16–39%) but four (2 PCOS; 2 without PCOS) demonstrated
decreases in GIR/FFM (mean change for whole cohort: 37%; 3–71%). Android-gynoid fat
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ratio (0.58; 0.51, 0.66 vs 0.46; 0.40, 0.51; P<0.01) was significantly higher and GIR/FFM
(6.69; 3.49, 9.90 vs 11.44; 9.15, 13.72 mg/kg/min; P = 0.01) was significantly lower in non-
responders compared with responders at baseline, but non-responders had significant post-
training decreases in android-gynoid ratio (-0.02; -0.04, -0.01; P = 0.03), and increases in
VO2 peak (7.24; 2.28, 12.21 mL/kg/min; P = 0.01) and GIR/FFM (1.44; 0.27, 2.61 mg/kg/
min; P = 0.02). In women with PCOS, pre-training VO2 peak was significantly negatively cor-
related with change in total body fat (r = -0.75; P = 0.02), and pre-training fasting glucose
negatively correlated with changes in VO2 peak (r = -0.76; P = 0.04), but positively corre-
lated with changes in GIR (r = 0.67; P = 0.046).
Conclusion
A high proportion of overweight and obese women with PCOS had small reductions in body
fat following a 12-week exercise intervention, but nevertheless significantly reduced relative
central adiposity and improved aerobic capacity and insulin sensitivity.
Introduction
Polycystic ovary syndrome (PCOS) affects up to one in five reproductive-aged women in Aus-
tralia and is associated with reproductive dysfunction, as well as metabolic consequences
including obesity, type 2 diabetes and cardiovascular disease [1]. Given the known benefits of
exercise targeting weight loss for preventing and reversing cardiometabolic conditions, exer-
cise is recommended as an important therapy for women with PCOS [2, 3]. However, we pre-
viously reported that a 12-week moderate to vigorous intensity exercise program failed to
normalise insulin sensitivity in overweight women with PCOS compared to overweight
women without PCOS [4]. Women with PCOS have also been observed to have significantly
smaller increases in growth hormone in response to exercise than controls [5].
Poor exercise responsiveness appears highly heritable [6] and may affect around 10% of
exercise participants in the general population [7]. However, modifiable factors, including
higher body fat and insulin resistance are common in women with PCOS [8, 9], and may
increase risk for poor exercise responsiveness in this population. It has been reported that 15–
20% of individuals with type 2 diabetes [10], and as many as 40% of middle-aged individuals at
high risk of type 2 diabetes [11], experience minimal improvements in metabolic health fol-
lowing exercise. Furthermore, higher total body fat mass is associated with smaller improve-
ments in physical function following an exercise intervention, irrespective of exercise
adherence in overweight and obese older adults [12]. It has been observed in overweight post-
menopausal women however that aerobic capacity significantly increases in response to exer-
cise even in those who do not reduce fat mass substantially [13]. Thus, although PCOS women
tend to have higher amounts of body fat [14], it is unclear whether this may also attenuate
exercise benefits and whether differences in body fat distribution are more important than
overall body fat for exercise responsiveness.
The aims of this secondary analysis of a 12-week exercise intervention in overweight
women with and without PCOS to determine factors associated with differential changes in
body fat, insulin resistance and aerobic capacity following a 12-week exercise intervention in
overweight and obese women with and without PCOS.
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Material and methods
Study design and participants
This study was a secondary analysis of a 12-week exercise intervention for overweight and
obese (BMI >25 kg/m2) and inactive (<100 minutes per week of self-reported moderate and
vigorous physical activity) women. Participants constituted a subset of a cross-sectional study
of pre-menopausal women with and without PCOS [4, 9, 15] and were recruited through com-
munity advertisements. The Monash Health Research Advisory and Ethics Committee
approved the study and participants gave written informed consent. All investigations were
conducted according to the principles expressed in the Declaration of Helsinki. The trial was
registered previously (ISRCTN84763265).
As described in Fig 1, 117 women were initially screened of whom 34 (n = 20 with PCOS;
n = 14 without PCOS) were eligible and consented to the exercise intervention. Thirteen
PCOS and eight non-PCOS women completed the study, and amongst these 16 (9 with PCOS
and 7 without PCOS) had complete body composition and insulin sensitivity data for this sec-
ondary analysis. Diagnosis of PCOS was undertaken by endocrinologists (S.K.H.) based on
meeting NIH criteria with demonstrating irregular menstrual cycles (21 or 35 days) and clini-
cal (hirsutism, acne) or biochemical (elevation of at least one circulating ovarian androgen)
hyperandrogenism. As these women were not assessed for polycystic ovaries on ultrasound,
they still meet the Rotterdam criteria but exact phenotype was unknown [16].
Fig 1. Consolidated Standards of Reporting Trials (CONSORT) flowchart describing progress
through the study.
https://doi.org/10.1371/journal.pone.0182412.g001
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Hyperprolactinemia, thyroid dysfunction and specific adrenal disorders were excluded clini-
cally and where indicated, biochemically. All women without PCOS had regular menses and
no evidence of clinical or biochemical hyperandrogenism. Exclusion criteria were age <20 or
>40 years, lipid-lowering agents, smoking, diabetes, recent weight change of 5 kilograms or
more in the previous six months, actively trying to lose weight and pregnancy.
At screening, standard diet and lifestyle advice were delivered based on recommendations
provided by the National Heart Foundation of Australia (www.heartfoundation.com.au) [17].
Medications known to affect end-points, including insulin sensitisers, anti- androgens and
hormonal contraceptives were ceased three-months prior to baseline. All data were collected
in the follicular phase for women without PCOS in order to minimise potential impact of
female reproductive hormones on study outcomes. However, as women with PCOS had irreg-
ular menses they were measured at times convenient to participants.
Exercise intervention
Participants undertook 12 weeks of supervised, progressive, moderate and vigorous exercise
training on a motorised treadmill [4, 15, 18]. Participants attended three 45–60 min sessions
supervised by study staff each week, which sequentially alternated between moderate-intensity
(20–60 minutes of walking or jogging at 75–80% of maximal heart rate [HRmax]) and high-
intensity interval training (six to eight five-minute intervals at *95–100% HRmax with two-
minute passive recovery periods). Participants progressed to eight repetitions by week four
and reduced recovery time to 1 minute by week eight. Target exercise heart rates were achieved
by altering speed and incline on the treadmill according to individual fitness [15]. Exercise
adherence was assessed by recording the number of sessions attended, and indicators of exer-
cise compliance were recorded, including total duration of exercise, total distance covered and
average heart rate assessed by heart rate monitors (Polar Electro Oy, Kempele, Finland).
Measurements
All measurements were obtained by study staff blinded to the PCOS status of participants.
Body weight and height were assessed and body mass index (BMI) calculated as weight (kilo-
grams) divided by height (metres) squared. Total body fat mass and fat-free mass, and android
and gynoid, fat mass were estimated by a whole-body dual energy X-ray absorptiometry
(DXA) scan (GE Lunar Prodigy, GE Lunar Corp, Madison WI, USA; operating system version
9). VO2 peak was assessed during a graded exercise test (GXT) on a motorised treadmill (Bio-
dex RTM 500, New York, USA) treadmill until volitional fatigue. Expired gases were collected
and analysed during the GXT using the MOXUS modular system (AEI Technologies, Pitts-
burgh, PA, USA). The Moxus was calibrated prior to each test with known gases (16% O2; 4%
CO2; BOC gases Australia) and volume (3L Hans Rudolph syringe).
The primary outcome was insulin sensitivity as measured by glucose infusion rate (mg/m2/
min) assessed by the euglycaemic–hyperinsulinaemic clamp technique as previously described
[15]. Clamp timing was standardised to 48 h after exercise and following a standardised high-
carbohydrate diet for 72 hours before an overnight fast. Insulin (Actrapid; Novo Nordisk,
Bagsvaerd, Denmark) was infused at 40 mU/m2 min for 120 min, with plasma glucose main-
tained at *5 mmol/L using variable infusion rates of 25% glucose. Glucose infusion rate
(GIR) was calculated during steady state, achieved in the last 30 minutes of the clamp and
expressed as glucose (mg) per kg of fat free mass per min (GIR/FFM). Stored blood samples
(-80˚C) were batch analysed for plasma fasting glucose and insulin, homeostatic model assess-
ment of insulin resistance (HOMA-IR) was calculated [9].
Metabolic responses to exercise in overweight and obese women with and without polycystic ovary syndrome
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Statistical analyses
Prior to analyses, data were assessed for normality by Shapiro-Wilk tests stratified by PCOS
status and fasting insulin and HOMA-IR were log transformed. Independent samples t-tests
compared changes in total body fat and VO2 peak from pre- to post-training in women with
and without PCOS. Independent samples t-tests and paired t-tests compared pre- and post-
exercise values for body composition, VO2 peak, and indicators of insulin resistance and exer-
cise compliance in women defined as exercise ‘responders’ (5% decrease in total body fat)
versus ‘non-responders’ (<5% decrease in total body fat) following training [13], and a chi-
square test compared proportions with and without PCOS. Pearson correlations stratified by
PCOS status examined associations of pre-training participant characteristics with post-train-
ing changes in body composition, VO2 peak and indicators of insulin resistance. All statistical
analyses were performed using SPSS version 23.0 (IBM, USA) and P-values<0.05 were con-
sidered statistically significant.
Results
Compared with the 18 participants who were excluded due to non-completion or missing data
(Table 1), the 16 included participants were of similar age (mean; 95% CI) (32.1 years; 29.4, 34.8
vs 32.1 years; 28.9, 35.3; P = 0.99), BMI (34.9 kg/m2; 31.9, 37.9 vs 36.29 kg/m2; 32.9, 39.4;
P = 0.55), and GIR/FFM (9.39; 7.02, 11.76 mg/kg/min vs 8.47; 6.13, 10.81 mg/kg/min; P = 0.56).
The majority of excluded participants were lost to contact (could not be contacted by phone or
email; 4) or refused to continue (due to time commitment; 1, vasovagal episode; 1, knee sore-
ness; 1, or no reason given; 5) in the exercise intervention by week six of the intervention. One
participant who completed the intervention was excluded due to a protocol violation (com-
menced significant sustained physical activity outside the intervention), and five had incom-
plete GIR/FFM data at baseline or follow-up (Fig 1). Amongst the included participants, four (3
Table 1. Comparison of pre-training and post-training values for body composition and cardiometabolic parameters according to exercise
responsiveness.
Pre-training Change to post-training
Non-Responders
(N = 10)
Responders
(N = 6)
Non-Responders; P-value for change
from pre-training
Responders; P-value for change from
pre-training
Age (y) 32.6 (28.6, 36.7) 31.2 (23.8, 38.6) - -
PCOS (%)* 70.0 33.3 - -
BMI (kg/m2) 36.5 (31.7, 41.4) 35.5 (30.0, 41.0) -0.46 (-1.03, 0.11); 0.10 -0.97 (-2.34, 0.40); 0.1
Fat-free mass (kg) 50.8 (45.0, 56.5) 48.4 (44.9, 51.9) -0.67 (-1.67, 0.33); 0.16 2.00 (0.99, 3.01); 0.01
Total fat mass (kg) 47.6 (39.3, 55.9) 47.0 (34.4, 59.7) -0.48 (-1.20, 0.23); 0.16 -4.48 (-7.32, -1.65); 0.01
Android fat (kg) 4.8 (3.8, 5.8) 4.0 (3.1, 4.9) -0.17 (-0.33, 0.01); 0.05 -0.40 (-0.60, -0.21); 0.01
Gynoid fat (kg) 8.2 (7.1, 9.3) 8.8 (6.4, 11.1) -0.02 (-0.22, 0.21); 0.98 -0.75 (-1.30, -0.20); 0.02
Android/gynoid ratio 0.58 (0.51, 0.66) 0.46 (0.40, 0.51)† -0.02 (-0.04, -0.01); 0.03 -0.01 (-0.03, 0.01); 0.32
VO2 peak (mL/kg/
min); n = 12
24.5 (20.0, 29.1) 28.2 (20.5, 35.9) 7.24 (2.28, 12.21); 0.01 (N = 6) 5.95 (3.47, 8.43); 0.01 (N = 6)
Glucose (mmol/L) 5.0 (4.6, 5.3) 4.8 (4.5, 5.0) 0.00 (-0.27, 0.27); 1.0 -0.10 (-0.43, 0.23); 0.47
Log Insulin 1.4 (1.2, 1.5) 1.2 (1.1, 1,3) -0.03 (-0.14, 0.07); 0.46 0.01 (-0.32, 0.34); 0.93
Log HOMA-IR 0.7 (0.5, 0.9) 0.5 (0.4, 0.7) -0.03 (-0.15, 0.08); 0.51 0.5 01 (-0.33, 0.34); 0.98
GIR/FFM (mg/kg/min) 6.7 (3.5, 9.9) 11.4 (9.2, 13.7)† 1.44 (0.27, 2.61); 0.02 1.57 (-1.44, 4.57); 0.239
All data are mean (95% CI) unless otherwise specified.
*Chi-square test
†Significantly different from non-responders (P = 0.01).
https://doi.org/10.1371/journal.pone.0182412.t001
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with PCOS, 1 without PCOS) did not have exercise tests either at baseline or follow-up and so
were excluded from analyses of change in VO2 peak. As demonstrated by the body fat, VO2
peak and GIR/FFM changes reported in Fig 2, there was a wide range of individual responses to
the exercise program. Ten (7 with PCOS and 3 without PCOS; P = 0.2) participants did not
Fig 2. Individual participant changes in total body fat (A), VO2 peak (B) and GIR/FFM (C) from pre- to
post-training according to PCOS status.
https://doi.org/10.1371/journal.pone.0182412.g002
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reduce their body fat by5%, and were classified as non-responders. Training decreased body
fat percentage by -2.3%; -5.3, 0.7% in women with PCOS and by -6.4%; -10.9, -1.9% in women
without PCOS (P-value for difference between groups = 0.08). Participants with PCOS lost less
gynoid fat compared with participants without PCOS (-0.02; -0.29, 0.24 kg vs -0.62; -1.14, -0.09
kg; P = 0.02). Conversely, all participants improved VO2 peak (27%; 16–39%) with no signifi-
cant differences between women with PCOS and those without (P = 0.21). Four (2 with PCOS;
2 without PCOS) participants demonstrated no improvement in GIR/FFM (mean change for
whole cohort: 37%; 3–71%) with no significant difference between groups (P = 0.39).
Baseline participant characteristics for exercise responders and non-responders defined
according to body fat changes are presented in Table 1. There were no differences in mean age
or PCOS status between groups. There were also no differences in total body fat, android and
gynoid fat mass, however android-gynoid ratio was significantly higher in non-responders.
Measures of insulin sensitivity were generally similar but GIR/FFM was significantly lower in
non-responders at baseline. Table 1 also presents post-training values for body composition
and indicators of insulin sensitivity according to exercise responsiveness. Total body fat,
android fat and gynoid fat were significantly decreased post-training in responders, although
the decrease in android fat in non-responders was of borderline significance (P = 0.05). Non-
responders had a significant decrease in android-gynoid ratio post-training. Both responders
and non-responders demonstrated a significant increase in VO2 peak, while only non-
responders had significant increases in insulin sensitivity as measured by GIR.
As demonstrated in Table 2, there were no differences between responders and non-
responders for exercise compliance or indicators of exercise workload. Women with PCOS
covered significantly higher mean distance than women without PCOS for the duration of the
intervention, however exercise workload (calculated as heart rate divided by distance covered
(bpm/km), was significantly higher in women without PCOS.
Pearson correlations were performed to examine associations of baseline characteristics
and exercise adherence/compliance in women with and without PCOS who completed the
intervention, and changes in body composition, VO2 peak and indicators of insulin sensitivity
from pre- to post-training. In women without PCOS, age was significantly positively correlated
with changes in fasting insulin in response to training (r = 0.76; P = 0.047) while higher total
body fat (r = -0.82; P = 0.03) and gynoid fat (r = -0.82; P = 0.03) at baseline were negatively cor-
related with changes in fasting glucose, and gynoid fat was also negatively correlated with
Table 2. Comparison of indicators of exercise adherence and compliance during the 12-week exercise intervention according to exercise respon-
siveness and PCOS status.
Non-Responders
(N = 10)
Responders
(N = 6)
P-value for difference
between groups
PCOS
(N = 9)
No PCOS
(N = 7)
P-value for difference
between groups
Total exercise sessions 32 (30, 33) 31 (29, 33) 0.79 32 (30, 34) 31 (29, 33) 0.74
Total exercise time (hrs) 29.7 (27.9, 31.5) 29.4 (26.2, 32.5) 0.82 30.1 (27.8,
32.5)
28.9 (27.1,
30.7)
0.37
Total exercise distance (km) 165.0 (28.0, 302.0) 77.0 (1.8, 155.9) 0.31 199.2 (55.7,
342.7)
46.1 (3.1,
89.0)
0.04
Mean exercise heart rate
(bpm)
153 (146, 160) 156 (150, 162) 0.45 153 (145,
161)
156 (152,
159)
0.49
Mean heart rate multiplied by
exercise time (bpm X hrs)
4500 (4275, 4725) 4580 (4157,
5004)
0.66 4562 (4307,
4816)
4489 (4144,
4833)
0.68
Mean heart rate/distance (bpm
/km)
3.9 (0.1, 7.8) 2.7 (0.3, 5.0) 0.49 1.4 (0.4,
2.3)
5.5 (2.0,
8.9)
0.03
All data are mean (95% CI).
https://doi.org/10.1371/journal.pone.0182412.t002
Metabolic responses to exercise in overweight and obese women with and without polycystic ovary syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0182412 August 3, 2017 7 / 13
change in gynoid fat (r = -0.77; P = 0.04). Baseline VO2 peak was negatively correlated with
changes in android-gynoid fat ratio in women without PCOS (r = -0.97; P = 0.01). None of the
baseline characteristics or exercise adherence/compliance indicators were associated with
change in VO2 peak in women without PCOS (all P>0.05). Total number of exercise sessions
was negatively correlated with change in fasting glucose (-0.76; P = 0.049).
As demonstrated in Fig 3A, baseline VO2 peak was significantly negatively correlated with
change in total body fat in women with PCOS, but not those without PCOS (two without
PCOS had missing VO2 peak data at baseline). Baseline VO2 peak was also negatively corre-
lated with change in gynoid fat (r = -0.69; P = 0.04) in women with PCOS. Baseline total body
(r = -0.67; P = 0.048) and gynoid (r = -0.73; P = 0.03) fat were negatively correlated with
change in android-gynoid ratio. Conversely, baseline android fat (r = 0.70; P = 0.04) and
Fig 3. Pearson correlations for associations of baseline VO2 peak with change in body fat (A) and for
baseline fasting glucose with change in GIR/FFM (B) according to PCOS status.
https://doi.org/10.1371/journal.pone.0182412.g003
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android-gynoid ratio (r = 0.72; P = 0.03) were positively correlated with change in gynoid fat.
Baseline fasting glucose was negatively correlated with change in VO2 peak (r-0.76; P = 0.046)
but also negatively correlated with change in glucose (r = -0.76; P = 0.02), and positively corre-
lated with change in GIR/FFM (Fig 3B). The only association observed between exercise
adherence and compliance indicators and exercise responsiveness in women with PCOS was a
positive correlation between total exercise distance and change in VO2 peak (0.82; P = 0.044).
Discussion
The primary findings of this secondary analysis of a 12-week intensified exercise intervention
in overweight and obese women with and without PCOS was a substantial variation in insulin
sensitivity, body fat and aerobic capacity changes in response to exercise, and although all par-
ticipants improved VO2 peak (indicating improved fitness), approximately one–quarter did
not improve insulin sensitivity and two-thirds did not reduce body fat by5%. Although pre-
vious research has suggested that exercise non-responsiveness can be overcome by increasing
exercise dose [19], we found few associations between indicators of exercise compliance and
workload with study outcomes. Rather, high fasting glucose was associated with poorer
improvements in VO2 peak, while lower baseline VO2 peak, higher relative central adiposity
and lower insulin sensitivity at baseline were all associated with smaller fat losses. Nevertheless,
despite smaller declines in total body fat, exercise non-responders significantly reduced rela-
tive central adiposity and improved aerobic capacity and insulin sensitivity. These findings
suggest that overweight and obese women with and without PCOS can obtain health benefits
from short-term exercise interventions even in the absence of significant body fat losses.
Women who failed to significantly reduce body fat in this study had significantly higher
baseline android-gynoid ratios and lower GIR/FFM pre-training than exercise responders,
and these associations are likely to be inter-related. In a recent study of normal weight PCOS
women, intra-, but not subcutaneous, abdominal fat was positively associated with fasting
insulin [20], supporting the concept that ectopic fat depots are more closely associated with
cardiometabolic health than subcutaneous depots [21]. A systematic review has demonstrated
that 15–20% of individuals with type 2 diabetes mellitus fail to improve metabolic health in
response to supervised exercise programs [10], suggesting that dysregulation of glucose
homeostasis (i.e high blood sugar levels, low insulin secretion and/or reduced insulin sensitiv-
ity) may be associated with poor exercise responsiveness in terms of body composition
changes. Individuals at high risk of developing type 2 diabetes who fail to improve insulin sen-
sitivity in response to an exercise program have increased transforming growth factor (TGF)-β
activity in skeletal muscle, suggesting inflammation may contribute to poorer improvements
on mitochondrial fuel oxidation and insulin sensitivity in this population [11]. Resistance to
the beneficial effects of exercise has been shown to be highly heritable, with heritability esti-
mates of almost 50% for VO2 peak in responses to exercise training [6]. However, the findings
of the present study suggest adjunct therapies which improve insulin sensitivity and body com-
position, such as caloric restriction, may enhance metabolic exercise responses in overweight
and obese women.
Despite losing small amounts of body fat following the 12-week exercise intervention, non-
responders demonstrated significant decreases in android-gynoid ratio. This highlights that
women who lose small amounts of fat in response to exercise may still undergo a shift to a
more metabolically healthy body composition, and is supported by the finding that VO2 peak
and GIR/FFM significantly improved in this group. An aerobic exercise and resistance training
intervention in 31 overweight and obese postmenopausal women had similar numbers of non-
responders (55%) as observed in our study (63%), despite its longer duration of 12 months
Metabolic responses to exercise in overweight and obese women with and without polycystic ovary syndrome
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[13]. Also similar to our study, the previous study observed higher BMI to be a predictor of
poor responsiveness, although they did not assess differences in body fat deposition. Neverthe-
less, the investigators reported that primary outcomes including muscle strength and VO2
peak increased similarly for responders and non-responders [13]. These findings indicate that
loss of body fat is not a limiting factor in improving aerobic capacity and insulin sensitivity in
women in response to exercise, and highlight the need to focus on end-points other than body
weight in interventions targeting overweight and obese individuals.
Several baseline characteristics were observed to be correlated with exercise-induced
changes in body composition and indicators of insulin sensitivity in women with PCOS, yet
these associations were somewhat controversial. For example, higher baseline total body and
gynoid fat were associated with greater declines in android-gynoid ratio, but higher baseline
android fat and android-gynoid ratio were associated with smaller declines in gynoid fat.
These conflicting findings are consistent with the concept that not all individuals are similarly
responsive to exercise training and potentially indicate that multi-component lifestyle modifi-
cation programs may be most beneficial for women with PCOS. For example, a 16-week pro-
gram of combined caloric restriction, behavioural modification, physical activity, and (for
obese women) weight loss medication, resulted in weight loss of over 6% in women with
PCOS [22], which is greater than the 2% weight loss observed in our intervention involving
exercise only [4]. Nevertheless, our findings have demonstrated that insulin resistance and aer-
obic capacity can improve in response to exercise even when fat does not substantially
decrease.
Higher baseline VO2 peak was associated with greater declines in total and gynoid fat in
women with PCOS, which was somewhat surprising given improvements might be expected
to be greater in those with the poorest cardiorespiratory fitness at baseline. Somewhat contro-
versially, higher baseline fasting glucose was associated with smaller increases in VO2 peak but
also with greater declines in fasting glucose, and greater increases in insulin sensitivity. The
association of higher fasting glucose with smaller increases in VO2 peak may be reflective of
the fact that higher levels of inflammatory markers and visceral fat are associated with lower
VO2 peak in women with PCOS [23], but is unexpected given that insulin sensitivity appeared
to be more likely to improve in women with PCOS who had higher fasting glucose at baseline.
This may demonstrate that improvements in insulin sensitivity in response to exercise in
women with PCOS do not necessarily associate with significant improvements in aerobic
capacity.
Only the number of exercise sessions attended and average heart rate achieved were predic-
tors for improvements in insulin sensitivity in women without PCOS. On the other hand, total
distance covered during the intervention was associated with improvements in aerobic capac-
ity in women with PCOS. A previous six-month exercise intervention also demonstrated
improvements in aerobic capacity in women with PCOS who were most compliant with train-
ing [24]. Interestingly, while we observed that women with PCOS covered significantly more
distance than those without PCOS in this intervention, the actual intensity or workload of
exercise appeared to be significantly lower. Given that a previous study suggests that increasing
exercise dose can abolish non-responsiveness [19], these findings highlight the need to maxi-
mise lifestyle program compliance and retention in women with PCOS [25], and suggest that
during training, motivational strategies that ensure higher levels of exertion are likely to be
beneficial.
A key limitation of this study was that there was substantial loss to follow-up resulting in
small numbers for comparison of women with and without PCOS and responders and non-
responders and therefore we were unable to control for potential confounders in multivariable
analyses. There is also potential for bias in our results from this loss to follow-up although we
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did not identify any differences in characteristics of included and excluded participants. The
sample size had only 79% power to detect a 10% difference in the primary outcome of insulin
sensitivity between exercise responders and non-responders (based on body fat change) sug-
gesting that it may have been inadequate to detect significant differences in other outcomes.
However, we observed 90% adherence amongst those who completed the exercise intervention
with no significant differences between women with and without PCOS [4], or between exer-
cise responders and non-responders. Furthermore, participants who completed the interven-
tion demonstrated 95% compliance to prescribed progressions in the exercise. We conducted
a short-term exercise intervention and it is unclear whether interventions of longer duration
would demonstrate similar associations between baseline characteristics and exercise non-
responsiveness. Nevertheless, an analysis of six exercise interventions with a minimum dura-
tion of four months reported substantial proportions of metabolic non-responders in all stud-
ies, suggesting increasing the duration of an exercise intervention is not sufficient to overcome
exercise non-responsiveness [7]. The strengths of our study include the gold-standard assess-
ments for body composition and insulin resistance, as well as objective assessments of exercise
adherence and compliance.
Conclusions
Although a high proportion of overweight and obese women with PCOS had small reductions
in total body fat following a 12-week exercise intervention, these exercise non-responders sig-
nificantly reduced relative central adiposity and improved aerobic capacity and insulin sensi-
tivity. Women with PCOS should be encouraged that participation in exercise, regardless of
the effect on body composition, it can result in significant improvements in metabolic health.
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